Patents for C07K 19 - Hybrid peptides (29,428) |
---|
08/05/2009 | CN100523188C Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof |
08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
08/05/2009 | CN100522242C Artificial proteins with reduced immunogenicity |
08/04/2009 | US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases |
08/04/2009 | US7569544 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
08/04/2009 | US7569226 Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
08/04/2009 | US7569225 Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
07/30/2009 | WO2009093118A1 Cell surface display of proteins |
07/30/2009 | WO2009068042A3 Novel peptides derived from ncam (fgls) |
07/30/2009 | WO2008145013A8 Fusion protein comprising targeting peptide of cd13 and lidamycin |
07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
07/30/2009 | US20090191581 Cell-permeable fluorescent proteins |
07/30/2009 | US20090191234 Vaccine |
07/30/2009 | US20090191196 Use |
07/30/2009 | US20090191154 Assembly and folding of fc-interferon-beta fusion proteins |
07/29/2009 | EP2083079A1 Apo-2DcR |
07/29/2009 | EP2083073A1 Reagent containing fused protein of soluble rankl with epitope tag |
07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
07/29/2009 | EP2083016A1 Bacterial superantigen vaccines |
07/29/2009 | EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
07/29/2009 | EP1549679B1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
07/29/2009 | CN101495516A CD33-specific single-chain immunotoxin and method of use |
07/29/2009 | CN101492508A Streptavidin/interleukins 15 amalgamation protein |
07/29/2009 | CN100519585C Fusion protein of P11 and SAK and its preparation method and use |
07/28/2009 | US7566777 Genes encoding hormone and lytic peptides |
07/28/2009 | US7566694 Anti-pathogen treatments |
07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
07/28/2009 | US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
07/23/2009 | WO2009064255A8 N-terminal xa27 signal anchor and its use for localization of fusion proteins |
07/23/2009 | WO2008127179A8 Fusion protein vaccine |
07/23/2009 | US20090186822 Thrombopoietic Compounds |
07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
07/22/2009 | EP2080772A2 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against TSH receptor |
07/22/2009 | EP2080771A2 New interferon beta-like molecules |
07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
07/22/2009 | EP2079526A1 Compositions and uses thereof in the treatment of wounds |
07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
07/22/2009 | CN101486768A Antigen protein for treating Alzheimer's disease and protein gene |
07/22/2009 | CN101486759A Human Toll-like receptor protein, related reagent and method |
07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
07/22/2009 | CN100516087C Recombinant target fusion protein GnRH-TNFam and its antitumor use |
07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
07/21/2009 | US7563760 P-selectin ligand protein |
07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
07/21/2009 | CA2329144C New peptide fragments for protein purification |
07/21/2009 | CA2133834C Process for preparing modified proteins |
07/16/2009 | WO2009089186A2 Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
07/16/2009 | WO2009087508A1 Production of heterologous proteins or peptides |
07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
07/16/2009 | US20090181049 Capsular polysaccharide solubilisation and combination vaccines |
07/16/2009 | US20090181045 Tat-based vaccine compositions and methods of making and using same |
07/16/2009 | US20090181041 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
07/16/2009 | CA2711691A1 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
07/15/2009 | EP2078082A1 Recombinant human interferon-like proteins |
07/15/2009 | EP2078041A2 Fusion proteins comprising two or more igg binding domains of streptococcal protein g. |
07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
07/15/2009 | CN101484472A Improved sgp130Fc dimers |
07/15/2009 | CN101481422A Antineoplastic target fusion protein with release switch and use thereof |
07/15/2009 | CN101481421A Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene |
07/15/2009 | CN101481420A Heterozygous antibacterial peptide CA-MA and recombinant expression method thereof |
07/15/2009 | CN101481419A Fusion protein of beta 2-microglobulin and green fluorescent protein, preparation and use thereof |
07/15/2009 | CN101481418A Fusion protein of tumor vascular targeted peptide and novel tumor necrosis factor |
07/15/2009 | CN100513548C Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms |
07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
07/14/2009 | US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
07/14/2009 | US7560431 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
07/14/2009 | US7560250 comprise a large heterologous polypeptide, such as a membrane protein, fused to a small soluble carrier polypeptide, which can be expressed by recombinant host cells in amounts and with solubility, purifiability and stability under crystallization conditions enabling their high-grade crystallization |
07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
07/10/2009 | CA2617691A1 Translocator component derivatives and uses thereof |
07/09/2009 | WO2009086126A2 Natriuretic polypeptides |
07/09/2009 | WO2008040190A8 Small peptides for anti-angiogenesis and use thereof |
07/09/2009 | WO2007112675A8 Vegf receptor fusion protein and use thereof |
07/09/2009 | WO2007109697A8 The use of protein s fusion for protein solubilization |
07/09/2009 | WO2007098548A8 A molecule and chimeric molecules thereof |
07/09/2009 | WO2007098547A8 A molecule and chimeric molecules thereof |
07/09/2009 | US20090176657 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
07/09/2009 | US20090175858 Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof |
07/09/2009 | US20090175850 NOGO Receptor Homologs |
07/09/2009 | US20090175821 Modified therapeutic peptides with extended half-lives in vivo |